CN114947032A - 一种能够改善血液质量、促进营养平衡的固体饮料 - Google Patents
一种能够改善血液质量、促进营养平衡的固体饮料 Download PDFInfo
- Publication number
- CN114947032A CN114947032A CN202210539350.XA CN202210539350A CN114947032A CN 114947032 A CN114947032 A CN 114947032A CN 202210539350 A CN202210539350 A CN 202210539350A CN 114947032 A CN114947032 A CN 114947032A
- Authority
- CN
- China
- Prior art keywords
- parts
- solid beverage
- improving blood
- blood quality
- promoting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008280 blood Substances 0.000 title claims abstract description 49
- 210000004369 blood Anatomy 0.000 title claims abstract description 48
- 235000013361 beverage Nutrition 0.000 title claims abstract description 44
- 239000007787 solid Substances 0.000 title claims abstract description 43
- 230000001737 promoting effect Effects 0.000 title claims abstract description 27
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 19
- 230000035764 nutrition Effects 0.000 title claims abstract description 10
- 239000000463 material Substances 0.000 claims abstract description 33
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 22
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 19
- 239000002994 raw material Substances 0.000 claims abstract description 17
- 239000007788 liquid Substances 0.000 claims abstract description 15
- 240000000249 Morus alba Species 0.000 claims abstract description 14
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 14
- 240000001417 Vigna umbellata Species 0.000 claims abstract description 14
- 235000011453 Vigna umbellata Nutrition 0.000 claims abstract description 14
- 239000000843 powder Substances 0.000 claims abstract description 14
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 11
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 11
- 235000012874 Phaseolus calcaratus Nutrition 0.000 claims abstract description 10
- 238000001035 drying Methods 0.000 claims abstract description 7
- 238000003756 stirring Methods 0.000 claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000008367 deionised water Substances 0.000 claims abstract description 4
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 4
- 238000002360 preparation method Methods 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims description 4
- 241000196324 Embryophyta Species 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 3
- 239000002552 dosage form Substances 0.000 claims description 3
- 235000013373 food additive Nutrition 0.000 claims description 3
- 239000002778 food additive Substances 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 239000006072 paste Substances 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 241000209514 Alismataceae Species 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 230000001105 regulatory effect Effects 0.000 abstract description 6
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 4
- 238000010521 absorption reaction Methods 0.000 abstract description 3
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 17
- 210000004185 liver Anatomy 0.000 description 12
- 210000004072 lung Anatomy 0.000 description 12
- 208000004880 Polyuria Diseases 0.000 description 10
- 230000035619 diuresis Effects 0.000 description 10
- 210000000952 spleen Anatomy 0.000 description 10
- 230000017531 blood circulation Effects 0.000 description 9
- 240000006509 Gynostemma pentaphyllum Species 0.000 description 8
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 description 8
- 208000002193 Pain Diseases 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 8
- 206010011224 Cough Diseases 0.000 description 7
- 230000001939 inductive effect Effects 0.000 description 7
- 230000008961 swelling Effects 0.000 description 7
- 208000032843 Hemorrhage Diseases 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 206010030113 Oedema Diseases 0.000 description 5
- 230000000740 bleeding effect Effects 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 4
- 241000735527 Eupatorium Species 0.000 description 4
- 241000180649 Panax notoginseng Species 0.000 description 4
- 235000003143 Panax notoginseng Nutrition 0.000 description 4
- 244000269722 Thea sinensis Species 0.000 description 4
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 208000031226 Hyperlipidaemia Diseases 0.000 description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 208000026106 cerebrovascular disease Diseases 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 235000008434 ginseng Nutrition 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 241000049624 Alisma plantago-aquatica subsp. orientale Species 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 244000061520 Angelica archangelica Species 0.000 description 2
- 206010065559 Cerebral arteriosclerosis Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 235000001287 Guettarda speciosa Nutrition 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 230000003143 atherosclerotic effect Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- -1 fashion drinks Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 201000005851 intracranial arteriosclerosis Diseases 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 244000144730 Amygdalus persica Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 241000092665 Atractylodes macrocephala Species 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 241001478385 Eupatorium japonicum Species 0.000 description 1
- 206010015967 Eye swelling Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- 240000007890 Leonurus cardiaca Species 0.000 description 1
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 235000003805 Musa ABB Group Nutrition 0.000 description 1
- 240000008790 Musa x paradisiaca Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010034038 Parotitis Diseases 0.000 description 1
- 235000015266 Plantago major Nutrition 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 241000304195 Salvia miltiorrhiza Species 0.000 description 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004377 improving vision Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000003863 physical function Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种能够改善血液质量、促进营养平衡的固体饮料,所述固体饮料包括下述质量份组分:抹茶16‑20份、三七粉8‑10份、决明子4‑5份、赤小豆3‑4份、桑叶3‑4份、泽泻3‑4份、泽兰3‑4份;该固体饮料的制备方法包括如下步骤:P1、按照质量份组分,选取各原料,备用;P2、得到基础物料;P3得到处理原料;P4、得到混合物料;P5、将混合物料按照固液比1:20‑30加入去离子水,均匀搅拌40秒至50秒,得到混合液体;P6、将混合液体进行二次浓缩和干燥,即可得到固体饮料,将各组分进行组合,协同作用,提供一种能够平衡营养、促进吸收,并且具有改善血液质量、辅助调节血脂的、适合糖尿病人群服用的固体饮料。
Description
技术领域
本发明涉及固体饮料技术领域,尤其涉及一种能够改善血液质量、促进营养平衡的固体饮料。
背景技术
在随着人们生活水平的提高,心脑血管疾病患病率呈现逐年上升趋势,血管是全身血液流通的管道,为身体的各个器官提供充足的养分和氧气支持。因此,血管的健康与否也成了现如今衡量一个人身体是否健康的一个标志。
血管是随着人们年龄的增加而逐渐老化,这也是为什么老年人患心血管疾病的概率会明显高于普通人的原因,但是近年来发病年龄不断呈年轻化趋势进展,在一些青壮年人甚至儿童的尸检中,也发现了早期的粥样硬化病变,有研究表明,此病变系多种因素作用于不同环节所致,这些因素被称为危险因素,主要包括高脂血症、高血压和糖尿病,高脂血症是冠心病,脑动脉硬化,脑血管意外等心脑疾病的易患因素之一,采取防治措施降低血脂水平,可以延缓动脉粥样硬化病变的发展,并能促进消退,从而降低冠心病、脑动脉硬化等的发病率及死亡率,已为人们所共识。
因此,提供一种辅助降血脂改善血液循环的固体饮料配方是相关领域内技术人员急需解决的问题。
发明内容
本发明的目的是为了解决现有技术中存在的缺点,而提出的一种能够改善血液质量、促进营养平衡的固体饮料。
为了实现上述目的,本发明采用了如下技术方案:
一种能够改善血液质量、促进营养平衡的固体饮料,所述固体饮料包括下述质量份组分:抹茶16-20份、三七粉8-10份、决明子4-5份、赤小豆3-4份、桑叶3-4份、泽泻3-4份、泽兰3-4份;
该固体饮料的制备方法包括如下步骤:
P1、按照质量份组分,选取各原料,备用;
P2、将各原料的基础原料采用传统工艺进行提取,得到基础物料;
P3、将基础物料进行浓缩和干燥处理,得到处理原料;
P4、将处理原料投入到混合机中,在50转每分钟至60转每分钟速率下均匀搅拌20分钟至30分钟,得到混合物料;
P5、将混合物料按照固液比1:20-30加入去离子水,均匀搅拌40秒至50秒,得到混合液体;
P6、将混合液体进行二次浓缩和干燥,即可得到固体饮料。
优选的,所述固体饮料包括抹茶18.75份,三七粉9.375份,决明子4.375份,赤小豆3.75份,桑叶3.75份,泽泻3.75份,泽兰3.125份。
优选的,所述固体饮料以50克为基础单位确定,组方如下:抹茶18.75克,三七粉9.375克,决明子4.375克,赤小豆3.75克,桑叶3.75克,泽泻3.75克,泽兰3,125克。
优选的,所述P2中的基础物料为其基础原料10:1的提取物。
优选的,所述固体饮料的基础物料均为植物材料。
优选的,所述泽泻为泽泻科植物泽泻的干燥块茎
优选的,所述固体饮料包括权利要求1-6所述的产物和制作的产品。
优选的,所述制作的产品包括但不限于以下剂型的产品,其中包括粉剂、颗粒剂、片剂、膏剂、胶囊、口服液、时尚饮料、食品添加剂。
本发明提供的一种能够改善血液质量、促进营养平衡的固体饮料,采用了具有利水渗湿、泄热、化浊降脂的功效的泽泻,有活血调经、散瘀消痈、利水消肿的功效的泽兰,能益肺气,清肺热,兼有化痰止咳之功的绞股蓝等多种药材相互配合,将各组分进行组合,协同作用,提供一种能够平衡营养、促进吸收,并且具有改善血液质量、辅助调节血脂的、适合糖尿病人群服用的固体饮料。
具体实施方式
为了使本发明的目的、技术方案及优点更加清楚明白,以下结合具体实施例,对本发明进行进一步详细说明。应当理解,此处所描述的具体实施例仅仅用以解释本发明,并不用于限定本发明。
一种能够改善血液质量、促进营养平衡的固体饮料,所述固体饮料包括下述质量份组分:抹茶16-20份、三七粉8-10份、决明子4-5份、赤小豆3-4份、桑叶3-4份、泽泻3-4份、泽兰3-4份;
该固体饮料的制备方法包括如下步骤:
P1、按照质量份组分,选取各原料,备用;
P2、将各原料的基础原料采用传统工艺进行提取,得到基础物料;
P3、将基础物料进行浓缩和干燥处理,得到处理原料;
P4、将处理原料投入到混合机中,在50转每分钟至60转每分钟速率下均匀搅拌20分钟至30分钟,得到混合物料;
P5、将混合物料按照固液比1:20-30加入去离子水,均匀搅拌40秒至50秒,得到混合液体;
P6、将混合液体进行二次浓缩和干燥,即可得到固体饮料。
作为优选的,所述固体饮料包括抹茶18.75份,三七粉9.375份,决明子4.375份,赤小豆3.75份,桑叶3.75份,泽泻3.75份,泽兰3.125份。
作为优选的,所述固体饮料以50克为基础单位确定,组方如下:抹茶18.75克,三七粉9.375克,决明子4.375克,赤小豆3.75克,桑叶3.75克,泽泻3.75克,泽兰3,125克。
作为优选的,所述P2中的基础物料为其基础原料10:1的提取物。
作为优选的,所述固体饮料的基础物料均为植物材料。
作为优选的,所述泽泻为泽泻科植物泽泻的干燥块茎
作为优选的,所述固体饮料包括权利要求1-6所述的产物和制作的产品。
作为优选的,所述制作的产品包括但不限于以下剂型的产品,其中包括粉剂、颗粒剂、片剂、膏剂、胶囊、口服液、时尚饮料、食品添加剂。
本发明提供的一种能够改善血液质量、促进营养平衡的固体饮料,采用了具有利水渗湿、泄热、化浊降脂的功效的泽泻,有活血调经、散瘀消痈、利水消肿的功效的泽兰,能益肺气,清肺热,兼有化痰止咳之功的绞股蓝等多种药材相互配合,将各组分进行组合,协同作用,提供一种能够平衡营养、促进吸收,并且具有改善血液质量、辅助调节血脂的、适合糖尿病人群服用的固体饮料。
其中,针对采用的药材物理的功效与作用分述如下:
第一、泽泻:泽泻为泽泻科植物泽泻的干燥块茎,主产于福建、四川等地,泽泻性寒,味甘、淡,归肾、膀胱经,具有利水渗湿、泄热、化浊降脂的功效。
第二、绞股蓝:有益气健脾、化痰止咳、清热解毒的作用。它适用于脾胃气虚、体倦乏力、纳食不佳者,绞股蓝性寒,味甘、苦,归脾、肺经。
功效:益气健脾、化痰止咳、清热解毒,作用:1.绞股蓝味甘入脾经,能益气健脾,适用于脾胃气虚,体倦乏力,纳食不佳者。
2.绞股蓝入肺经,能益肺气,清肺热,兼有化痰止咳之功。
3.绞股蓝还略有清热解毒作用,可用于肿瘤而有热毒之症。
4.除了入方剂以外,绞股蓝可以用来代茶饮,一般是把绞股蓝用开水泡服以后,放温以后使用。
3、泽兰:泽兰苦、辛、微温,归肝、脾经,有活血调经、散瘀消痈、利水消肿的功效,可以治疗血瘀导致的闭经,以及产后瘀血、腹痛,本品辛散温通,行而不峻,善于活血调经,为妇科经产瘀血中的重要药物。
如果血瘀导致月经不调、闭经、痛经、产后瘀血、腹痛,泽兰可以配伍当归、丹参、益母草,本品可治疗跌打损伤,淤血肿痛,泽兰有活血、化瘀、消肿的作用,治疗跌打损伤可以单用本品捣烂或配伍当归、红花、桃仁,泽兰既能活血,又能利水消肿,对于瘀血阻滞,水血互结,产后浮肿,可以配合白术、车前子。
第三、桑叶:桑叶性寒,味苦、甘,归肺及肝经,有疏散风热、清肺润燥、平抑肝阳、清肝明目的作用,可以治疗风热感冒、温病初起,常与菊花配伍使用,还可以治疗肺热咳嗽、燥热咳嗽,除此之外还可以治疗肝阳上亢导致的眩晕,目暗昏花以及各种出血证,煎汤内服用量在5g-9g之间,一般在秋天第一次霜后采摘,叫霜桑叶,霜桑叶疗效最好。
第四、决明子:性甘、苦、咸,微寒,入肝、胆经,清肝明目,润肠通便,降血压,降低胆固醇,决明子,颜色青黄光洁,外形如谷粒,青色入肝,对于肝经风热所引起的眼睛分泌物增多,流眼泪目,目赤肿痛,眼睛干涩不舒,视力疲劳,视物昏花,头晕等,能够起到清肝明目的作用,对于肠道津亏所引起的大便秘结,能够起到润肠通便的作用,对于动脉硬化,高血压,高脂血症,能够起到治疗作用,食用方法:入煎剂,水煎服或者是泡水作为茶疗,需要注意的是,对于脾胃虚寒,久泻便溏者忌用。
第五、赤小豆:赤小豆有健脾去湿、解毒排脓、利水消肿、行血补血、利尿通淋的功效,还有治疗水痘、急性肾炎、腮腺炎、肝硬化腹水炎性外痔,皮肤病等作用,其抗氧化和稳定女性体内的雌激素水平也有一定疗效。
第六、小豆,性味甘、酸,平,归心、小肠经,既可以食用,又可以入药,赤小豆用于中药里,可用于治疗淋证,黄疸等疾病,其利尿通淋、除湿退黄,但外用要适量,研末调敷内服常用量为9到30g。
第七、三七:三七是比较常用的止血药物,它的性味是甘、微苦、温,归肝、胃经,因此在功效上有化瘀止血、活血定痛的作用,在主治上化瘀止血,主要是针对人体内外各种出血病症均可治疗,而活血定痛可用于治疗跌打损伤、瘀滞肿痛,痈疡肿痛的形成多由于气血瘀滞不通有关,因此也取三七散瘀止痛、活血消肿的力量,对于已溃的患者可以助气血、生肌敛疮的作用,自明代以来,临床医家非常重视三七的药物作用,认为三七为化瘀止血、消肿定痛之良药,因此用于治疗咯血、吐血、衄血、便血、崩漏、外伤出血、胸腹刺痛、跌扑、肿痛,《本草纲目拾遗》里曾说人参补气第一,三七补血第一,味同而功亦等,故称人参三七,为中药最珍贵者,因此,三七是有止血兼补血的作用,在现代药理研究,三七的主要作用成分是三七总皂甙,有类似人参的皂甙成分,因此具有类似人参抗衰老、抗氧化、调节免疫的作用,在现代临床当中可以用来增加冠脉的血流量,降低耗氧量,同时具有保肝、镇静、安神的作用。
第八、茶叶:茶叶味苦、甘,微寒,入心、肺、脾经,茶叶有清热降火、祛风解暑的作用。
Claims (8)
1.一种能够改善血液质量、促进营养平衡的固体饮料,其特征在于:所述固体饮料包括下述质量份组分:抹茶16-20份、三七粉8-10份、决明子4-5份、赤小豆3-4份、桑叶3-4份、泽泻3-4份、泽兰3-4份;
该固体饮料的制备方法包括如下步骤:
P1、按照质量份组分,选取各原料,备用;
P2、将各原料的基础原料采用传统工艺进行提取,得到基础物料;
P3、将基础物料进行浓缩和干燥处理,得到处理原料;
P4、将处理原料投入到混合机中,在50转每分钟至60转每分钟速率下均匀搅拌20分钟至30分钟,得到混合物料;
P5、将混合物料按照固液比1:20-30加入去离子水,均匀搅拌40秒至50秒,得到混合液体;
P6、将混合液体进行二次浓缩和干燥,即可得到固体饮料。
2.根据权利要求1所述的一种能够改善血液质量、促进营养平衡的固体饮料,其特征在于:所述固体饮料包括抹茶18.75份,三七粉9.375份,决明子4.375份,赤小豆3.75份,桑叶3.75份,泽泻3.75份,泽兰3.125份。
3.根据权利要求1所述的一种能够改善血液质量、促进营养平衡的固体饮料,其特征在于:所述固体饮料以50克为基础单位确定,组方如下:抹茶18.75克,三七粉9.375克,决明子4.375克,赤小豆3.75克,桑叶3.75克,泽泻3.75克,泽兰3,125克。
4.根据权利要求1所述的一种能够改善血液质量、促进营养平衡的固体饮料,其特征在于:所述P2中的基础物料为其基础原料10:1的提取物。
5.根据权利要求1所述的一种能够改善血液质量、促进营养平衡的固体饮料,其特征在于:所述固体饮料的基础物料均为植物材料。
6.根据权利要求1所述的一种能够改善血液质量、促进营养平衡的固体饮料,其特征在于:所述泽泻为泽泻科植物泽泻的干燥块茎。
7.根据权利要求1所述的一种能够改善血液质量、促进营养平衡的固体饮料,其特征在于:所述固体饮料包括权利要求1-6所述的产物和制作的产品。
8.根据权利要求7所述的一种能够改善血液质量、促进营养平衡的固体饮料,其特征在于:所述制作的产品包括但不限于以下剂型的产品,其中包括粉剂、颗粒剂、片剂、膏剂、胶囊、口服液、时尚饮料、食品添加剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210539350.XA CN114947032A (zh) | 2022-05-17 | 2022-05-17 | 一种能够改善血液质量、促进营养平衡的固体饮料 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210539350.XA CN114947032A (zh) | 2022-05-17 | 2022-05-17 | 一种能够改善血液质量、促进营养平衡的固体饮料 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114947032A true CN114947032A (zh) | 2022-08-30 |
Family
ID=82983983
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210539350.XA Pending CN114947032A (zh) | 2022-05-17 | 2022-05-17 | 一种能够改善血液质量、促进营养平衡的固体饮料 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114947032A (zh) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1357368A (zh) * | 2001-12-25 | 2002-07-10 | 岳小鸥 | 保健饮品 |
CN105053311A (zh) * | 2015-07-07 | 2015-11-18 | 杭州茗宝食品有限公司 | 一种抹茶固体饮料及其生产方法 |
CN105998198A (zh) * | 2016-07-28 | 2016-10-12 | 岳小鸥 | 改善“三高症”的保健品及其制备方法 |
CN106074871A (zh) * | 2016-08-16 | 2016-11-09 | 余桂火 | 一种治疗高血压、高血脂、糖尿病的中药制剂及制备方法 |
CN109364163A (zh) * | 2018-12-14 | 2019-02-22 | 辽宁美罗君元药业有限公司 | 一种具有降血脂功能的中药制剂及其制备方法 |
CN112136998A (zh) * | 2020-09-02 | 2020-12-29 | 岳康医疗生物科技有限公司 | 辅助降血脂改善血液循环的固体饮料配方及其制备方法 |
-
2022
- 2022-05-17 CN CN202210539350.XA patent/CN114947032A/zh active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1357368A (zh) * | 2001-12-25 | 2002-07-10 | 岳小鸥 | 保健饮品 |
CN105053311A (zh) * | 2015-07-07 | 2015-11-18 | 杭州茗宝食品有限公司 | 一种抹茶固体饮料及其生产方法 |
CN105998198A (zh) * | 2016-07-28 | 2016-10-12 | 岳小鸥 | 改善“三高症”的保健品及其制备方法 |
CN106074871A (zh) * | 2016-08-16 | 2016-11-09 | 余桂火 | 一种治疗高血压、高血脂、糖尿病的中药制剂及制备方法 |
CN109364163A (zh) * | 2018-12-14 | 2019-02-22 | 辽宁美罗君元药业有限公司 | 一种具有降血脂功能的中药制剂及其制备方法 |
CN112136998A (zh) * | 2020-09-02 | 2020-12-29 | 岳康医疗生物科技有限公司 | 辅助降血脂改善血液循环的固体饮料配方及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106035860A (zh) | 一种减肥降压养生袋装茶及其制备方法 | |
CN109793879A (zh) | 一种适宜女性补气养血的黄精桃仁制品及其制备方法 | |
CN109170014A (zh) | 一种石斛保健茶及其制备方法 | |
CN111758874A (zh) | 一种调理气血状态的养生固体饮料及其制备方法 | |
CN1068222C (zh) | 保健茶及其配制方法 | |
CN110959708A (zh) | 一种降糖茶及其制备方法 | |
CN104474487A (zh) | 补脾和胃酒 | |
CN114947032A (zh) | 一种能够改善血液质量、促进营养平衡的固体饮料 | |
CN111481600A (zh) | 补肾膏 | |
CN106072290A (zh) | 一种可减少孕吐又可补充营养的羹汤及制备方法 | |
CN105381220A (zh) | 一种明目降脂的菟丝子保健茶 | |
CN113209243A (zh) | 一种酒、制备方法及用途 | |
CN104922504A (zh) | 治疗动脉粥样硬化的醋饮及制备方法 | |
CN111471560A (zh) | 一种茶黄素保健酒及其制备方法 | |
CN110584037A (zh) | 一种食品人参膏及其制备方法 | |
CN106798044A (zh) | 一种党参补中益气果味茶膏及其制备方法 | |
CN105362940A (zh) | 一种降血脂降胆固醇保健口服液及其制备方法 | |
CN106367273A (zh) | 一种百香果果酒及其酿造方法 | |
CN105918912A (zh) | 一种产后瘦身的菌菇鸵鸟肉丸药膳及制备方法 | |
CN104825879A (zh) | 临床护理用健脾补肾胶囊及制备方法 | |
CN105106600A (zh) | 一种促进因车祸致脑部外伤手术后愈合的组合物及制法 | |
CN115531483A (zh) | 一种祛瘀茶及其制备方法 | |
CN116076639A (zh) | 一种抗疲劳提高免疫力的保健饮品及其制备工艺 | |
CN104435365A (zh) | 一种防治心血管疾病的养心通脉饮及其制备方法 | |
CN112156159A (zh) | 一种调理片及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |